Evelo Biosciences to Participate in Upcoming Investor Conferences in September

On September 8, 2020 Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, reported that management will participate in two upcoming virtual investor conferences in September (Press release, Evelo Biosciences, SEP 8, 2020, View Source [SID1234564731]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 18th Annual Global Healthcare Conference. Management will host a fireside chat at 4:30 p.m. ET on Monday, September 14, 2020.

Cantor Fitzgerald’s Virtual Global Healthcare Conference 2020. Management will participate in 1×1 meetings on Thursday, September 17, 2020.

A live audio webcast of the Morgan Stanley fireside chat will be available on the Investors section of the Evelo website at View Source A replay of the webcast will be available for approximately 30 days following the presentation.